» Articles » PMID: 35011637

Three-Dimensional Genome Organization in Breast and Gynecological Cancers: How Chromatin Folding Influences Tumorigenic Transcriptional Programs

Overview
Journal Cells
Publisher MDPI
Date 2022 Jan 11
PMID 35011637
Authors
Affiliations
Soon will be listed here.
Abstract

A growing body of research on the transcriptome and cancer genome has demonstrated that many gynecological tumor-specific gene mutations are located in cis-regulatory elements. Through chromosomal looping, cis-regulatory elements interact which each other to control gene expression by bringing distant regulatory elements, such as enhancers and insulators, into close proximity with promoters. It is well known that chromatin connections may be disrupted in cancer cells, promoting transcriptional dysregulation and the expression of abnormal tumor suppressor genes and oncogenes. In this review, we examine the roles of alterations in 3D chromatin interactions. This includes changes in CTCF protein function, cancer-risk single nucleotide polymorphisms, viral integration, and hormonal response as part of the mechanisms that lead to the acquisition of enhancers or super-enhancers. The translocation of existing enhancers, as well as enhancer loss or acquisition of insulator elements that interact with gene promoters, is also revised. Remarkably, similar processes that modify 3D chromatin contacts in gene promoters may also influence the expression of non-coding RNAs, such as long non-coding RNAs (lncRNAs) and microRNAs (miRNAs), which have emerged as key regulators of gene expression in a variety of cancers, including gynecological malignancies.

Citing Articles

Unexpected nuclear hormone receptor and chromatin dynamics regulate estrous cycle dependent gene expression.

Jefferson W, Wang T, Padilla-Banks E, Williams C Nucleic Acids Res. 2024; 52(18):10897-10917.

PMID: 39166489 PMC: 11472041. DOI: 10.1093/nar/gkae714.


Chromatin insulation orchestrates matrix metalloproteinase gene cluster expression reprogramming in aggressive breast cancer tumors.

Llinas-Arias P, Ensenyat-Mendez M, Iniguez-Munoz S, Orozco J, Valdez B, Salomon M Mol Cancer. 2023; 22(1):190.

PMID: 38017545 PMC: 10683115. DOI: 10.1186/s12943-023-01906-8.


A novel PTEN mutant caused by polymorphism in cis-regulatory elements is involved in chemosensitivity in breast cancer.

Wang J, Zhang S, Zhang J, Zhang Z, Ma Q, Fu W Am J Cancer Res. 2023; 13(1):86-104.

PMID: 36777516 PMC: 9906080.


Revisiting the miR-200 Family: A Clan of Five Siblings with Essential Roles in Development and Disease.

Sundararajan V, Burk U, Bajdak-Rusinek K Biomolecules. 2022; 12(6).

PMID: 35740906 PMC: 9221129. DOI: 10.3390/biom12060781.

References
1.
Lawrence M, Stojanov P, Mermel C, Robinson J, Garraway L, Golub T . Discovery and saturation analysis of cancer genes across 21 tumour types. Nature. 2014; 505(7484):495-501. PMC: 4048962. DOI: 10.1038/nature12912. View

2.
Gu F, Pfeiffer R, Bhattacharjee S, Han S, Taylor P, Berndt S . Common genetic variants in the 9p21 region and their associations with multiple tumours. Br J Cancer. 2013; 108(6):1378-86. PMC: 3619272. DOI: 10.1038/bjc.2013.7. View

3.
Xi W, Beer M . Loop competition and extrusion model predicts CTCF interaction specificity. Nat Commun. 2021; 12(1):1046. PMC: 7886907. DOI: 10.1038/s41467-021-21368-0. View

4.
Sun Q, Hao Q, Prasanth K . Nuclear Long Noncoding RNAs: Key Regulators of Gene Expression. Trends Genet. 2017; 34(2):142-157. PMC: 6002860. DOI: 10.1016/j.tig.2017.11.005. View

5.
Cremer T, Cremer M, Dietzel S, Muller S, Solovei I, Fakan S . Chromosome territories--a functional nuclear landscape. Curr Opin Cell Biol. 2006; 18(3):307-16. DOI: 10.1016/j.ceb.2006.04.007. View